| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |